Cargando…

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes

Following the emergence and global spread of a novel H1N1 influenza virus in 2009, two A(H1N1)pdm/09 influenza vaccines produced from the A/California/07/09 H1N1 strain were selected and used for the national immunisation programme in the United Kingdom: an adjuvanted split virion vaccine and a non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefevre, Eric A., Carr, B. Veronica, Inman, Charlotte F., Prentice, Helen, Brown, Ian H., Brookes, Sharon M., Garcon, Fanny, Hill, Michelle L., Iqbal, Munir, Elderfield, Ruth A., Barclay, Wendy S., Gubbins, Simon, Bailey, Mick, Charleston, Bryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302873/ https://www.ncbi.nlm.nih.gov/pubmed/22427834 http://dx.doi.org/10.1371/journal.pone.0032400

Ejemplares similares

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
por: Friel, Damien, et al.
Publicado: (2020)

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response
por: Madsen, Anders, et al.
Publicado: (2021)

H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses
por: Santini-Oliveira, Marilia, et al.
Publicado: (2012)

Vaccine Adjuvant Nanotechnologies
por: Barclay, T., et al.
Publicado: (2017)

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial()
por: Yang, William H., et al.
Publicado: (2013)

Magnitude and Kinetics of T Cell and Antibody Responses During H1N1pdm09 Infection in Inbred Babraham Pigs and Outbred Pigs
por: Edmans, Matthew, et al.
Publicado: (2021)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Timelines of infection and transmission dynamics of H1N1pdm09 in swine
por: Canini, Laetitia, et al.
Publicado: (2020)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
por: Garcia-Sicilia, José, et al.
Publicado: (2015)

Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine
por: Quintana, Luis F., et al.
Publicado: (2012)

Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C
por: Ohfuji, Satoko, et al.
Publicado: (2012)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

Accumulation of Human-Adapting Mutations during Circulation of A(H1N1)pdm09 Influenza Virus in Humans in the United Kingdom
por: Elderfield, Ruth A., et al.
Publicado: (2014)

Vaccine Adjuvants: from 1920 to 2015 and Beyond
por: Di Pasquale, Alberta, et al.
Publicado: (2015)

Safety assessment of adjuvanted vaccines: Methodological considerations
por: Da Silva, Fernanda Tavares, et al.
Publicado: (2015)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel
por: Weil, Merav, et al.
Publicado: (2012)

High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity
por: Matsuoka, Toshihiko, et al.
Publicado: (2016)

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains
por: Lartey, Sarah, et al.
Publicado: (2015)

Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants
por: Pashine, Achal, et al.
Publicado: (2006)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials
por: Vaughn, David W, et al.
Publicado: (2014)

CD4(+) T-cell responses to foot-and-mouth disease virus in vaccinated cattle
por: Carr, B. Veronica, et al.
Publicado: (2013)

Innate and adaptive immune responses in patients with pandemic influenza A(H1N1)pdm09
por: Huang, Yu, et al.
Publicado: (2013)

No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
por: Mahmud, Salaheddin M., et al.
Publicado: (2012)

Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: Results of a randomized trial
por: Scheifele, David W., et al.
Publicado: (2013)

Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination
por: Kobiyama, Kouji, et al.
Publicado: (2013)

Modulation of Primary Immune Response by Different Vaccine Adjuvants
por: Ciabattini, Annalisa, et al.
Publicado: (2016)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

Combination of Innate Immune Modulators as Vaccine Adjuvants in Mice
por: Haddadi, Azita, et al.
Publicado: (2020)

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
por: Grant, Clare FJ, et al.
Publicado: (2012)

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Vaccines and adjuvants
por: Wilkie, Bruce
Publicado: (1993)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dc06m8umebl3qeklnm9qpjm8kt